1 Min Read
Dec 14 (Reuters) - Sihuan Pharmaceutical Holdings Group Ltd
* internally developed innovative patented new drug “fadanafil” granted approval from CFDA for phase i/ii/iii clinical trials Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.